Opthea has announced key leadership appointments to strengthen its commercial and clinical capabilit...
read moreBlueRock Therapeutics, a subsidiary of Bayer, announced that the FDA has cleared its investigational...
read moreMany conditions can mimic dry eye disease (DED), leading to misdiagnoses and ineffective treatments,...
read moreA new study titled “Prevalence of Glaucoma Among US Adults in 2022”, published in JAMA Ophthalmology...
read moreA recent study presented at the American Academy of Ophthalmology (AAO) meeting in Chicago has ident...
read moreCataract surgery is well-known for restoring vision, but a new study reveals it may also play a vita...
read moreArtificial intelligence (AI) is emerging as a valuable tool in diagnosing infectious keratitis (IK),...
read moreA new investigational drug, ANX007, offers hope for the millions of people suffering from geographic...
read moreA new study led by researchers from the Perelman School of Medicine at the University of Pennsylvani...
read moreAt the 2024 American Academy of Ophthalmology (AAO) meeting in Chicago, Dr. SriniVas R. Sadda discus...
read more